Milton J. Arras,, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 501 Robertson Blvd, Walterboro, SC 29488 Phone: 843-549-0520 Fax: 843-549-0466 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced that it has submitted a MAA to the European Medicines Agency for velaglucerase alfa, the company's enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease.
Natural sugars found in breast milk that are now included in prebiotic foods may help in the fight against Salmonella and other food poisoning bacteria, scientists heard at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.
Orthopedic surgeon Paul Cooper, MD, says, "In the 12 years I've been a foot and ankle surgeon, this is the most exciting thing I've been able to offer my patients."
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today reported that it had received a Warning Letter from the Food and Drug Administration ("FDA") alleging that its Deconsal CT chewable tablets (Phenylephrine HCl 10 mg, Pyrilamine Maleate 16 mg) and Deconsal DM chewable tablets (Phenylephrine HCl 10 mg, Pyrilamine Maleate 16 mg, Dextromothorphan HBr 15 mg) are new drugs lacking an approved application and as such should not be introduced into interstate commerce.
› Verified 7 days ago